The highest tissue concentrations of GAWK-LI were found in pheochromocytoma 18, 173±3,915; 17, 852±2,763 [mean±SEMJ pmol/g wet wt tissue; n = 9), which were at least ten times higher than any other tumors producing GAWK-LI. High concentrations of GAWK-LI were also found in other types of endocrine tumors including carcinoid, medullary carcinoma of thyroid, pancreatic, and ACrH-producing lung tumors. On the other hand, low concentrations of GAWK-LI were found in nonendocrine tumors.
Introduction
A partial sequence of chromogranin-B (420-493) has been isolated from the human pituitary and designated GAWK (1-3; Fig. 1 ). The family of proteins called chromogranins, originally found in chromaffin cells (4) , are now thought to be universal markers for neuroendocrine tissues and tumors (5) (6) (7) (8) (9) (10) (11) (12) (13) . Recently the amino acid sequences of human chromogranin A (CgA) and B (CgB) have been reported and shown to be very different from each other, particularly in the central section (3, 14) . Thus, there is no GAWK sequence anywhere within the CgA molecule. One ofthe proposed functions ofthe chromogranins is that they are precursors of peptide hormones. For example, the sequence of pancreastatin, a peptide that may be involved in the regulation of insulin secretion, is contained within CgA (14, 15) . The GAWK sequence is contained within CgB but as yet has not been shown to have a physiological role. Histochemical and RIA studies have shown the concentration of CgA to be elevated in endocrine tumors (6) (7) (8) (9) (10) (16) (17) (18) (19) . However, the concentrations ofCgB or the CgB fragment peptide (GAWK) in endocrine tumors and plasma have not previously been reported. We developed two RIA systems using antibodies to GAWK (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) and GAWK (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) to measure GAWK-like immunoreactivities (GAWK [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] -LI) in different types of endocrine tumors and in plasma obtained from patients with those tumors before and after removal by surgery. GAWK-LI was characterized by chromatography and the concentration of GAWK-LI was measured in plasma from the adrenal and peripheral veins to investigate the possible source of circulating GAWK-LI. In addition, localization of GAWK-LI in tissue sections of endocrine tumors was carried out by immunocytochemistry.
Methods
Tissues. Endocrine tumor tissues (n = 194) were obtained at surgical resection. Immediately after removal the tissues were snap-frozen in liquid nitrogen and stored at -70'C or below for subsequent peptide extraction or fixed by immersion in Bouin's solution for-histological examination. Specimens of normal human pancreas (n = 8; one obtained at operation, seven at postmortem; median, 13 .3 h; range, 5.5-28 h after death) and adrenal gland (n = 15; nine operative, six postmortem; median, 12.0 h; range, 6-24 h after death) were obtained. These tissues, thought clinically not to be involved in any pathological process, were subjected to microscopic examination and only included if shown to be histologically normal.
Tissue extraction. Tissues for RIA were extracted in 0.5 M acetic acid (10 ml/g wet wt tissue) for (20) . 16 half lop-eared rabbits were immunized with the conjugate emulsified in complete Freund's adjuvant for the primary immunization and incomplete adjuvant for booster injection. Two rabbits, one named YEA4 for GAWK (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) and the other named YS-I for GAWK (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) , produced antisera of sufficiently high affinity to be useful for both RIAs of plasma samples, tissue extracts, and immunocytochemistry. The optimal dilutions for RIA were found to be 1:16,000 for YE-4 and 1:24,000 for YS-1. The antisera were characterized by assessing their ability to bind labeled synthetic GAWK fiagments. No '251-GAWK fragments were used as standards and tracers. lodination of the GAWK fragments was performed by the chloramine-T method (21) . Purification of the iodinated product was performed by reverse phase HPLC using a 5-jum Techsil C-18 column (3.9 X 300 mm) and eluted with 17.5% (vol/vol) acetonitrile (ACN) in 0.1% (vol/vol) 1 . Abbreviations used in this paper: ACN, acetonitrile; FPLC, fast protein liquid chromatography; GH, growth hormone; GRH, GH-releasing hormone; Kav, elution coefficient; MEA, multiple endocrine adenomatosis; PRL, prolactin; SRIF, somatostatin; TFA, trifluoracetic acid; VIP, vasoactive intestinal polypeptide; VIPomas, vasoactive intestinal peptide-producing tumors. aqueous trifluoracetic acid (TFA) for GAWK (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) and 30% (vol/vol) ACN M 0.1% aqueous TFA for GAWK (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) . The specific activity of GAWK (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) and GAWK (20-38) labels, as estimated by the self-displacement method (22) , was 38 and 56 Becquerel/fmol, respectively. Standards were prepared gravimetrically from the synthetic GAWK fragments, Iyophilized, and stored in vacuo at -20'C. Tissue extracts were assayed in duplicate using 0.1, 1, or 10 sl. The assay was performed in a total vol of0.8 ml of phosphate buffer (0.06 M, pH 7.4; 0.01 M EDTA and 0.3% ofBSA). For assay ofplasma 1-, 10-, or I00-d samples were used in duplicate. After 4 d incubation at 4VC, free '251-GAWK was separated from antibody-bound '251I-GAWK by adsorption of the latter to dextran-coated charcoal (6 mg/tube). These assays were capable of detecting changes (i.e., hormone additions) between assay tubes of 0.5 (GAWK [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] -LI) and 0.2 fmol (GAWK [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] -LI) with 95% confidence. The dilution curves of plasma samples and tumor extracts, including VIPomas and pheochromocytomas, showed parallelism to both assay standards. The intra-assay variation ofthe GAWK (1-17) assay ranged from 12.3% at 12.4 pmol/liter(l1.24 fmol/tube) to 6.8% at 134 pmol/liter (13.4 fmol/tube, n = 7), with corresponding interassay variations of 22 and 11% (n = 10), respectively. The intra-assay variation of the GAWK (20-38) assay ranged from 11.3% at 9.8 pmol/liter (0.98 fmol/tube) to 5.2% at 205 pmol/ liter (20.5 fmol/tube, n = 7) with corresponding interassay variations of 18 and 7.8% (n = 10), respectively.
Immunocytochemistry. Wax sections (5 Mm) of Bouin's solutionfixed endocrine tumors (see Table II ) and normal adrenal gland were cut and allowed to dry on poly-L-lysine-coated slides (23) overnight at 37°C. Dewaxed sections were immunostained by the peroxidase antiperoxidase technique (24) using antisera YE-4 and YS-at a dilution of 1-400. Control immunostaining included replacement of primary antisera with nonimmune serum, absorption of the antisera with homologous antigen, or absorption of YS-1 with GAWK (1-17) and of YE-4 with GAWK (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) . A range ofconcentrations of antigens was used (0.1-10 nmol/ml diluted antiserum).
Gel chromatographic procedures. Gel permeation chromatography ofselected tumor extracts and plasma samples was performed on a 1.5 X 100-cm column of Sephadex G-50 superfine (Pharmacia, Uppsala, Sweden). The column was eluted at 4°C with phosphate buffer (0.06 M, pH 7.4; 0.01 M EDTA; 0.3% BSA; and 0.2 M NaCI) at a flow rate of 3.2 ml/h, and 0.8 ml was collected per fraction tube. The column was calibrated with dextran blue (2,000,000 mol wt), horse heart cytochrome c (12,384 mol wt), and a trace amount of '25I-Na as a bed volume marker. The eluted fractions and applied samples were assayed by both GAWK (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) and GAWK (20-38) RIAs. The recovery of all column runs was 76-125%.
Fast protein liquid chromatography (FPLC). Selected tumor extracts, which had been prepared by passing through Minisart NML filter (0.2 Am, SM 16534; Sartorius, Gottingen, FRG), were subjected to reverse phase FPLC on a PepRPC column (C-18; Pharmacia). A gradient from 5-35% solvent B (solvent A, water in 0.1% TFA; solvent B, ACN in 0.1% TFA) over 60 min was followed by another gradient from 35-50% solvent B over 10 min. The flow rate was I ml/min, and l-ml fractions were collected for subsequent assay of both GAWK (1-17)-LI and GAWK (20- 17 ,852±2,763 pmol/g), which were at least 10 times higher than any other GAWK-LI-producing tumors, were found in pheochromocytoma tissues. High concentrations of GAWK-LI were also found in carcinoid tumors, medullary carcinoma of thyroid, pancreatic endocrine tumors, ACTH-producing lung tumors, and a glomus tumor. On the other hand, low concentrations of GAWK-LI were found in nonendocrine tumors (e.g., squamous cell carcinomas and adenocarcinomas).
Immunocytochemistry. The results obtained for endocrine tumors using immunocytochemistry are displayed in Table II . Immunostaining of GAWK (20-38) (antiserum YS-1) gave more positive results than that of GAWK (1-17) (antiserum YE-4). Consistent positive staining was seen with both antisera in all pheochromocytomas studied (six of six; Fig. 2 ) and for YS-1 (GAWK 20-38) in all mid-gut carcinoid tumors (six of six; Fig. 3 ). The other types of endocrine tumors showed variable degrees ofGAWK-LI, except for the nine cases of pulmonary small cell carcinoma which were all negative for both antisera. In addition, GAWK (20-38), but not GAWK (1-17), could be immunostained in cells of normal adrenal medulla (Fig. 4) . Antisera specificity test showed that immunostaining Fig. 5 .
Elevated plasma GAWK-LI was found in patients with pancreatic endocrine tumors (except gastrinomas), carcinoid tumors, and islet cell carcinomas. On the other hand, plasma concentrations of GAWK-LI were mostly normal in patients with pituitary tumors (ACTH-, GH-, and PRL-producing tumors), adrenal cortex tumors including one aldosteroneproducing tumor, nonendocrine tumors including adeno or squamous cell carcinomas, and medullary carcinoma of thyroid, and also in patients with duodenal ulcer and gastric ulcer. Neither were plasma levels of GAWK-LI greatly elevated in patients with pheochromocytomas and multiple endocrine adenomatosis (types 1 and 2; MEA). Patients suspected of having a VIPoma (n = 36), with high plasma VIP-like immunoreactivity levels (> 30 pmol/liter plasma) but no pancreatic tumor on radiological levels of GAWK-LI, were in the normal ranges without exception. After successful tumor excision in patients with demonstrable VIPoma (n = 4) and pheochromocytoma (n = 1), plasma levels of GAWK-LI decreased to normal values (Fig. 6 ). Plasma concentrations of GAWK (20-38)-LI in the adrenal vein (266±51 pmol/liter, mean±SEM) was approximately four times higher than that in peripheral samples (67±10 pmol/liter, P < 0.005, n = 12; (Fig. 8) . In almost all profiles of these samples, two major GAWK (20- 26-0.27) were also noted. However, in pheochromocytomas and normal adrenal glands major peaks were found near the void volume, and the profiles from these tissues were strikingly similar. The profiles of the pancreatic endocrine tumors were also similar to each other and to those of the lung tumors, medullary carcinoma of thyroid, ganglioneuroblastoma, and normal pancreas. Fig. 9 shows gel chromatographic profiles of plasma samples from patients with endocrine tumors (VIPoma and pheochromocytoma) and a normal subject. In the plasma of patients with VIPoma and pheochromocytoma, three GAWK (20-38)-LI peaks were found in the same positions as those of matched tumor extracts. On the other hand, the peak of GAWK 
Discussion
In this study, immunoreactivity indicative of GAWK (chromogranin-B 420-493) was found in high concentrations in a elevated plasma GAWK-LI levels, and these were only moderately raised. The same phenomenon was also observed in gastrinoma and medullary carcinoma of thyroid patients. recurrence after prospective studies in large numbers of patients, and it is now necessary to investigate these possibilities.
